Market Cap (In CNY)
29.09 Billion
Revenue (In CNY)
2.1 Billion
Net Income (In CNY)
555.44 Million
Avg. Volume
1.69 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 46.3-86.11
- PE
- -
- EPS
- -
- Beta Value
- 0.43
- ISIN
- CNE100003RT3
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Li Sun
- Employee Count
- -
- Website
- https://www.amoytop.com
- Ipo Date
- 2020-01-17
- Details
- Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs using genetic engineering technology in China. It offers formulations, reagents, and APIs, as well as custom-manufacturing services. The company was founded in 1996 and is based in Xiamen, China.
More Stocks
-
002240
-
8613
-
MANTAMandatum Oyj
MANTA
-
CONTROLPRControl Print Limited
CONTROLPR
-
TCVNFTocvan Ventures Corp.
TCVNF
-
PFIEProfire Energy, Inc.
PFIE
-
CBGH
-
002678